6-BROMO-3-CHLORO-2-METHYLIMIDAZO[1,2-A]PYRIMIDINE, 95.0%, 250mg

N,N-Diisopropylethylamine, min. 99%, for synthesis, 250 ml, glass packaging

2-Bromo-1-ethylpyridinium tetrafluoroborate, 98.0%, 10g

3,3',5,5'-Tetra-tert-butyl-2,2'-dihydroxybiphenyl>98.0%(GC)1g

4-Oxotetrahydropyran, 98.0%, 100g

4-Ethylcyclohexanecarboxylic acid, 95.0%, 250mg

6-Bromoquinoline-3-carbaldehyde, 95.0%, 5g

2-Fluoro-1,1-dimethyl-ethylamine hydrochloride, 95.0%, 1g

Sodium bis(trimethylsilyl)amide 1M in THF, 100g

3-[5-ethyl-7-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid, 95.0%, 250mg

Methyl 4-methyltetrahydro-2H-pyran-4-carboxylate, 95.0%, 250mg

(S)-Dimethyl pyrrolidine-1,2-dicarboxylate, 95+%, 500mg

N3,N3,N6,N6-Tetramethylacridine-3,6-diamine, 95.0%, 5g